about
Predictors of incomplete immunization coverage among one to five years old children in TogoPolio vaccine hesitancy in the networks and neighborhoods of Malegaon, India.Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series.Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in AfricaExtending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccinesPriming after a Fractional Dose of Inactivated Poliovirus VaccinePrevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka
P50
Q36130236-CA45D42E-333D-475D-988A-19D86B13BDA7Q39988083-74105F3C-C47B-4397-91BA-FCBD3EC7C981Q42183588-09725731-6B58-44C4-A153-22D56D336F5CQ52628920-8A611E69-D2FE-4F90-B03D-3D5EF0D22EA2Q57663467-204D2BD0-288F-4B75-A52A-8FDD51228C52Q60634668-38364A8E-768C-471F-95E4-33730B62E1C3Q60634679-4CBC6766-0DFC-493B-B6A3-B52DBDA8DA98Q60634683-4C6D7D14-429E-4C49-BECE-C17D69EA57FE
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anna-Lea Kahn
@ast
Anna-Lea Kahn
@en
Anna-Lea Kahn
@es
Anna-Lea Kahn
@nl
type
label
Anna-Lea Kahn
@ast
Anna-Lea Kahn
@en
Anna-Lea Kahn
@es
Anna-Lea Kahn
@nl
prefLabel
Anna-Lea Kahn
@ast
Anna-Lea Kahn
@en
Anna-Lea Kahn
@es
Anna-Lea Kahn
@nl
P106
P21
P31
P496
0000-0001-8565-2814